RMR Wealth Builders
Source: SEC Form 13F · as of Mar 2026RMR Wealth Builders holds 16 biotech & pharma companies tracked by BioSniper, totaling $25.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$25.7M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 6,020 | $5.5M |
| JNJJOHNSON & JOHNSON | 17,434 | $4.3M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 7,110 | $3.2M |
| REGNREGENERON PHARMACEUTICALS, INC. | 3,873 | $3.0M |
| GILDGILEAD SCIENCES, INC. | 13,884 | $1.9M |
| GMOptec International, Inc. | 23,983 | $1.8M |
| MRKMerck & Co., Inc. | 13,066 | $1.6M |
| ABBVAbbVie Inc. | 7,176 | $1.6M |
| PMPhilip Morris International Inc | 3,208 | $530K |
| MCKMcKesson Corporation | 554 | $480K |
| ELANElanco Animal Health Inc | 19,773 | $473K |
| BMYBRISTOL MYERS SQUIBB CO | 7,391 | $448K |
| IDXXIDEXX LABORATORIES INC /DE | 505 | $284K |
| AMGNAMGEN INC | 675 | $237K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 783 | $212K |
| ABTABBOTT LABORATORIES | 2,006 | $206K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.